- Report
- January 2024
- 315 Pages
Global
From €2447EUR$2,688USD£2,078GBP
€3495EUR$3,840USD£2,969GBP
- Report
- January 2024
- 250 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- June 2023
- 236 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- February 2023
- 240 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- October 2022
- 265 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- December 2021
- 190 Pages
Global
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP
- Book
- February 2024
- 928 Pages
- Book
- February 2023
- 576 Pages
- Book
- December 2022
- 464 Pages
- Book
- October 2022
- 816 Pages
- Book
- April 2022
- 480 Pages
- Book
- April 2022
- 496 Pages
- Book
- February 2022
- 560 Pages
- Book
- December 2021
- 576 Pages
- Book
- December 2021
- 624 Pages

Bioavailability is a term used to describe the degree and rate at which a drug is absorbed into the bloodstream. It is an important factor in drug delivery, as it determines the effectiveness of a drug. Bioavailability is affected by the route of administration, the formulation of the drug, and the patient's physiology.
Drug delivery systems are designed to improve the bioavailability of drugs, allowing them to be more effectively absorbed into the bloodstream. These systems can include oral, transdermal, and injectable delivery methods. Oral delivery is the most common, and involves the administration of a drug in pill or liquid form. Transdermal delivery involves the application of a drug to the skin, while injectable delivery involves the injection of a drug directly into the bloodstream.
Companies in the bioavailability market include Novartis, Pfizer, Merck, and Johnson & Johnson. These companies develop and manufacture drug delivery systems, as well as drugs themselves, to improve the bioavailability of their products. Show Less Read more